Cyclosporine induces different responses in human epithelial, endothelial and fibroblast cell cultures

Kidney International

Volumn 58, Issue 1, 2000, Pages 123-130

  Esposito, Ciro ^a,b   Fornoni, Alessia ^a   Cornacchia, Flavia ^a   Bellotti, Nicoletta ^a   Fasoli, Gianluca ^a   Foschi, Annalisa ^a   Mazzucchelli, Iolanda ^a   Mazzullo, Tiziana ^a   Semeraro, Luca ^a   Canton, Antonio Dal ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Apoptosis; Cell proliferation; Matrix turnover; Nitric oxide; Transplantation

Indexed keywords

CYCLOSPORIN;

APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CELL PROLIFERATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM CELL; EPITHELIUM CELL; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; HUMAN CELL; KIDNEY EPITHELIUM; NEPHROTOXICITY; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

EID: 20244385940     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00147.x     Document Type: Article

References (35)

1. 1. MYERS BD, ROSS J, NEWTON L, LUETSHER J, PERLROTH M: Cyclosporine-associated chronic nephropathy. N Engl J Med 311: 699-705, 1984
2. 2. WOOLFSON RG, NEILD GH: Cyclosporin nephrotoxicity following cardiac transplantation. Nephrol Dial Transplant 12:2054-2056, 1997
3. 3. FEUTREN G, MIHATSCH MJ: Risk factors for cyclosporin-induced nephropathy in patients with autoimmune disease. N Engl J Med 326:1654-1660, 1992
4. 4. BARNHART GR, PASCOE EA, MILLS SA, SZENTPETERY S, EICH DM, MOHANAKUMAR T, HASTILLO A, THOMPSON JA, HESS ML, LOWER RR: Accelerated coronary arteriosclerosis in cardiac transplant recipients. Transplant Rev 1:31-46, 1987
5. 5. GRIFFITHS MH, CROWE AV, PAPADAKI L, BANNER NR, YACOUB MH, THOMPSON FD, NEILD GH: Cyclosporin nephrotoxicity in heart and lung transplant patients. Q J Med 89:751-763, 1996
6. 6. PERICO N, DETCHEVA A, KHALIL EI, REMUZZI G: Cyclosporine induces glomerulosclerosis: Three-dimensional definition of the lesions in a rat model of renal transplant. Kidney Int 49:1283-1288, 1996
7. 7. EVANS SM, GIDDINGS JC, MURAKI T, YAMAMOTO J: Expression of von Willebrand factor, P-selectin (CD62P) and thrombomodulin in human endothelial cells in culture modulated by cyclosporin A. Clin Lab Haematol 19:115-120, 1997
8. 8. YOKOKAWA K, KOHNO M, MINAMI M, YASUNARI K, MANDAL AK, YOSHIKAWA J: Heparin suppresses cyclosporine-induced endothelin-1 synthesis in rat endothelial cells. J Cardiovasc Pharmacol 31:S460-S463, 1998
9. 9. GERLACH H, ESPOSITO C, STERN D: Modulation of endothelial hemostatic properties: An active role in the host response. Annu Rev Med 41:15-24, 1990
10. 10. TRUONG LD, FARHOOD A, TASBY J, GILLUM D: Experimental chronic ischemia: Morphology and immunologic studies. Kidney Int 41:1676-1689, 1992
11. 11. STOROGENKO M, PECH-AMSELLEM MA, KERDINE S, ROUSSELET F, PALLARDY M: Cyclosporin-A inhibits human endothelial cells proliferation through interleukin-6-dependent mechanisms. Life Sci 60:1487-1496, 1997
12. 12. ESPOSITO C, FASOLI G, FORNONI A, CORNACCHIA F, BELLOTTI N, FOSCHI A, MAZZULLO T, SEMERARO L, MAESTRI M, DAL CANTON A: Cyclosporine A inhibits cell growth and induces apoptosis in porcine and human renal tubular cells. Haematologica 83:74-75, 1998
13. 13. ESPOSITO C, FUIANO G, DAL CANTON A: Endothelial cells, in Immunopharmacology of the Renal System, edited by TETTA C, London, Academic Press, 1993, pp 34-48
14. 14. NICOLETTI I, MIGLIORATI G, PAGLIACCI MC, GRIGNANI F, RICCARDI C: A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271-279, 1991
15. 15N] nitrate in biological fluid. Anal Biochem 126:131-138, 1982
16. 16. HE CJ, ESPOSITO C, PHILLIPS C, ZALUPS RK, HENDERSON DA, STRIKER GE, STRIKER LJ: Dissociation of glomerulosclerosis, glomerular hypertrophy and cell proliferation in mouse strains heterozygous for a mutation (Os) which induces a 50% reduction in nephron number. J Clin Invest 97:1242-1249, 1996
17. 17. MONCADA S, PALMER RMJ, HIGGS EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142, 1991
18. 18. OKUNO S, SHIMIZU S, ITO T, NOMURA M, HAMADA E, TSUJMOTO Y, MATSUDA H: Bcl-2 prevents caspase-independent cell death. J Biol Chem 273:34272-34277, 1998
19. 19. SHIHAB FS, ANDOH TF, TANNER AM, NOBLE NA, BORDER WA, FRANCESCHINI N, BENNETT WM: Role of transforming growth factor-α1 in experimental chronic cyclosporine nephrotoxicity. Kidney Int 49:1141-1151, 1996
20. 20. HOUSEN B, DEMERTZIS S, ROHDE R, ALBES JM, SCHAFERS HJ, BORST HG: Low-dose cyclosporine therapy in triple-drug immunosuppression for heart transplant recipients. Ann Thorac Surg 58:999-1004, 1994
21. 21. WU MS, YU HM, HONG JJ, HUANG CC, VANDEWALLE A: Cyclosporine, but not FK 506 and rapamycin, enhances cell proliferation in mouse medullary thick ascending cultured cells. Transplant Proc 30:3565-3566, 1998
22. 22. MARIOTTI A, HASSELL T, JACOBS D, MANNING CJ, HEFTI AF: Cyclosporine A and hydroxycyclosporine (M-17) affect the secretory phenotype of human gingival fibroblasts. J Oral Pathol Med 27:260-266, 1998
23. 23. TAVARES P, MARTINEZ-SALGADO C, ELENO N, TEIXEIRA F, LOPEZ NOVOA JM: Effect of cyclosporine A on rat smooth-muscle cell proliferation. J Cardiovasc Pharmacol 31:46-49, 1998
24. 24. YANG CW, KIM HA, KIM YK, YOON SN, LEE JK, KIM BK, BANG BK: Inhibition of cellular proliferation by cyclosporine A during compensatory renal growth: Flow cytometric analysis. Am J Nephrol 17:483-486, 1997
25. 25. THOMAS SE, ANDOH TF, PICHLER RH, SHANKLAND SJ, COUSER WJ, BENNETT WM, JOHNSON RJ: Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney Int 53:897-908, 1998
26. 26. ORTIZ A, CORINA L, MARINA C, ORTIZ A, SANTIAGO C, JESUS E: Cyclosporine A induces apoptosis in murine tubular epithelial cells: Role of caspases. Kidney Int 54:S25-S29, 1998
27. 27. HEALY E, DEMPSEY M, LALLY C, RYAN MP: Apoptosis and necrosis: Mechanisms of cell death induced by cyclosporine A in renal proximal tubular cell line. Kidney Int 54:1955-1966, 1998
28. 28. SARIH M, SOUVANNAVONG V, ADAM A: Nitric oxide synthase induces macrophage death by apoptosis. Biochem Biophys Res Commun 191:503-508, 1993
29. 29. NAVARRO-ANTOLIN J, HERNANDEZ-PERERA O, LOPEZ-ONGIL S, RODRIGUEZ-PUYOL M, RODRIGUEZ-PUYOL D, LAMAS S: CsA and FK506 up-regulate eNOS expression: Role of reactive oxygen species and AP-1. Kidney Int 54:S20-S24, 1998
30. 30. ORIJI GK, KEISER HR: Role of nitric oxide in cyclosporine A-induced hypertension. Hypertension 32:849-855, 1998
31. 31. STRIKER GE, HE CJ, LIU ZH, YANG CCW, ZALUPS R, ESPOSITO C, STRIKER LJ: Pathogenesis of non-immune glomerulosclerosis: Studies in animal and potential application to man. Lab Invest 73:1-10, 1995
32. 32. ROSS R: Atherosclerosis: An inflammatory disease. N Engl J Med 340:115-126, 1999
33. 33. WOESSNER FJ: Matrix metalloproteinases and their inhibitors in connective tissue remodelling. FASEB J 5:2145-2154, 1991
34. 34. JOHNSON DW, SAUNDERS HJ, JONSON FJ, HUQ SO, FIELD MJ, POLLOCK CA: Cyclosporin exerts a direct fibrogenic effect on human tubulointerstitial cells: Roles of insulin-like growth factor I, transforming growth factor α1, and platelet-derived growth factor. J Pharmacol Exp Ther 289:535-542, 1999
35. 35. DUYMELINCK C, DENG JT, DAUWE SEH, DE BROE ME, VERPOOTEN GE: Inhibition of the matrix metalloproteinase system in a rat model of chronic cyclosporine nephropathy. Kidney Int 54:804-818, 1998